2019
home
January
About
A new drug, Ibrutinib, which can also be taken as a daily pill -- rather than being given by infusion -- has proved more effective as therapy against so-called chronic lymphocytic leukaemia than standard therapy in older patients.
Contact: info@neat-news.com. neat-news.com is not responsible for the content of external sites. We do not link to external sites in return for money or any other benefits. The page is maintained in Germany and for any legal matters the laws of Germany apply. neat-news.com © 2019.